Adenosine

8 trials 5 recruiting CCardiology

Filter these 8 trials by condition, phase, country and more.

Open in Search →

8 Registered trials

5 Recruiting

1 Completed trials

7 Sponsors

11 Countries

Phase III

Phase II

Phase IV

Phase III: 2 Phase II: 4 Phase IV: 2

Indications tested

Coronary artery disease 3

Sponsors using this IMP

Synektik S.A. 2 Corflow Therapeutics AG 1 Region Hovedstaden 1 Region Skane 1 Vaestra Goetalandsregionen 1 Vastra Gotalandsregionen 1 Xylocor Therapeutics Inc. 1

All trials

8 total

Prognostic Performance of Quantitative Myocardial Perfusion Imaging Using H2[15O] Positron Emission Tomography in Coronary Artery Disease - … Pending

2024-518706-41-01 Phase III 1 country Vaestra Goetalandsregionen
REVITALISE Study Pending

2025-522060-32-00 Phase II 3 countries Corflow Therapeutics AG
Colchicine for ischemia with no obstructive coronary artery disease and microvascular dysfunction Recruiting

2023-507981-17-00 Phase II 1 country Region Hovedstaden
HYPER-trial Hyperemic mYocardial Perfusion by adEnosine at diffeRent doses Recruiting

2023-505248-20-00 Phase IV 1 country Region Skane
Absolute quantification of myocardial blood flow in human subjects with SYN2 dynamic PET imaging Recruiting

2023-507520-23-00 Phase II 1 country Synektik S.A.
A Phase III Prospective, Multicenter, Open-label Study to Assess Diagnostic Efficacy of a Novel 18F-labelled Tracer, SYN2, for Positron Emis… Recruiting

2023-506971-89-00 Phase III 5 countries Synektik S.A.
Optimized pharmacologic treatment for broken heart (takotsubo) syndrome Recruiting

2022-501874-21-00 Phase IV 3 countries Vastra Gotalandsregionen
A study to evaluate the safety and effectiveness of a new gene therapy (XC001) for people with coronary artery disease and reduced heart fun… Ended

2025-521325-33-00 Phase II 4 countries Xylocor Therapeutics Inc.

Showing 1–8 of 8 trials

← All drugs A–Z